Document Detail


N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH.
MedLine Citation:
PMID:  18092166     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Systemic sclerosis (SSc) is characterized by vascular dysfunction that may lead to pulmonary artery hypertension (PAH). The N-terminal pro-B type natriuretic peptide (NT-proNBP), a marker of cardiac failure, is a diagnostic marker of early PAH in patients with SSc without heart failure. Our aim was to determine whether NT-proBNP levels may be a useful tool to evaluate the response to bosentan therapy in patients with PAH secondary to SSc. Ten patients with symptomatic, severe PAH secondary to SSc, received bosentan, 62.5 mg twice a day for 4 weeks followed by 125 mg twice a day for 7 months. Ten patients with SSc without PAH served as controls for basal level of NT-proBNP. Blood samples were obtained before the beginning of the therapy and after 3 and 7 months of treatment. SSc patients with PAH had significantly higher serum levels of NT-proBNP than those without PAH, at baseline. After 3 and 7 months of therapy, NT-proBNP concentration showed a progressive decrease, nearly approaching statistical difference at 7 months when compared to baseline levels (P=0.953 and P=0.600). Our results show that serum NT-proBNP levels may be a useful marker for the response to bosentan therapy in patients with PAH secondary to SSc.
Authors:
Sara Simeoni; Giuseppe Lippi; Antonio Puccetti; Martina Montagnana; Elisa Tinazzi; Daniele Prati; Roberto Corrocher; Claudio Lunardi
Related Documents :
15921796 - Pre-discharge b-type natriuretic peptide predicts early recurrence of decompensated hea...
20360066 - Plasma tissue inhibitor of matrix metalloproteinase-1 (timp-1): an independent predicto...
19398076 - Reduction in bnp levels with treatment of decompensated heart failure and future clinic...
8247356 - The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the...
18457356 - Infrared radiation spectrum of acupuncture point on patients with coronary heart disease.
22326876 - Lateral asymmetry and reduced forward masking effect in early brainstem auditory evoked...
Publication Detail:
Type:  Journal Article     Date:  2007-12-19
Journal Detail:
Title:  Rheumatology international     Volume:  28     ISSN:  0172-8172     ISO Abbreviation:  Rheumatol. Int.     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-04-08     Completed Date:  2008-07-24     Revised Date:  2013-06-18    
Medline Journal Info:
Nlm Unique ID:  8206885     Medline TA:  Rheumatol Int     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  657-60     Citation Subset:  IM    
Affiliation:
Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, Policlinico GB Rossi, P.le LA Scuro 37134, Verona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Female
Humans
Hypertension, Pulmonary / blood,  drug therapy*
Male
Middle Aged
Natriuretic Peptide, Brain / blood*
Peptide Fragments / blood*
Scleroderma, Systemic / blood,  complications*
Sulfonamides / therapeutic use*
Chemical
Reg. No./Substance:
0/Peptide Fragments; 0/Sulfonamides; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain; Q326023R30/bosentan
Comments/Corrections
Comment In:
Rheumatol Int. 2009 Jan;29(3):347-8   [PMID:  18690444 ]
Rheumatol Int. 2008 Nov;29(1):115   [PMID:  18500454 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma.
Next Document:  TREX1 polymorphisms associated with autoantibodies in patients with systemic lupus erythematosus.